Clinical Trials for A Combination of Adoptive T Cell Therapy and Ipilimumab Could Increase the Proportion of CR Patients, and Durability of Response
Find clinical trials for a combination of adoptive t cell therapy and ipilimumab could increase the proportion of cr patients, and durability of response. Discover research opportunities and treatment options in your area.
No Active Trials Found
There are currently no active clinical trials for a combination of adoptive t cell therapy and ipilimumab could increase the proportion of cr patients, and durability of response in our database.
Condition: A Combination of Adoptive T Cell Therapy and Ipilimumab Could Increase the Proportion of CR Patients, and Durability of Response